A study recently published in the BMJ’s Journal of Neurology, Neurosurgery, and Psychiatry found that a digital interactive therapy tool designed for multiple sclerosis patients, Gaia’s Elevida, was effective in reducing MS-related fatigue.
from MobiHealthNews https://ift.tt/2IpBzXr
April 02, 2018
Rose
MobiHealthNews
No comments
Related Posts:
athenahealth reveals mobile app Epocrates Connect for EHR coordinationathenahealth will be debuting Epocrates Connect, a mobile app that directly connects into a provider’s EHR system, at HIMSS 2018 next week. The system uses machine learning and language processing to give providers access to … Read More
Precision Health AI launches new platform to synthesize oncology dataArtificial intelligence has been working its way into the field of research. Now Precision Health AI, a company that specializes in applications of AI to oncology, has just launched a new platform, called Eureka Health O… Read More
Helix raises $200 million to grow genomics testing marketplaceHelix has closed a $200 million financing round and said it plans to expand its personal genomics marketplace to accelerate consumer adoption of genomics. from MobiHealthNews http://ift.tt/2t9Iwce … Read More
PlushCare taps Thermo Fisher Scientific to offer telemedicine allergy consultationsPlushCare, a direct-to-consumer telemedicine service that originally focused on acute and urgent care, has partnered with Thermo Fisher Scientific to add allergy testing to its offerings. PlushCare users will have access to T… Read More
Novartis, Pear Therapeutics sign development deal for two digital therapeuticsPear Therapeutics has inked a deal with pharma company Novartis to work together on the development of two digital therapeutics for multiple sclerosis and schizophrenia. It’s the first time a pharma company has made a develop… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment